Walleye Capital’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$437K Buy
+8,695
New +$492K ﹤0.01% 4204
2026
Q2
– Sell
-18,425
Closed -$1.02M – 4715
2026
Q1
$1.02M Buy
+18,425
New +$991K ﹤0.01% 2056
2025
Q4
– Sell
-56,422
Closed -$1.73M – 4524
2025
Q3
$1.73M Buy
+56,422
New +$1.29M 0.01% 1685
2024
Q4
– Sell
-163,997
Closed -$5.49M – 4801
2024
Q3
$5.49M Buy
+163,997
New +$5.6M 0.01% 1113
2024
Q2
– Sell
-9,015
Closed -$203K – 5551
2024
Q1
$203K Buy
+9,015
New +$213K ﹤0.01% 3965
2023
Q2
– Sell
-10,235
Closed -$223K – 4275
2023
Q1
$223K Sell
10,235
-1,144
-10% -$27.8K ﹤0.01% 2391
2022
Q4
$353K Buy
+11,379
New +$321K 0.01% 1679
2022
Q1
– Sell
-77,784
Closed -$2.7M – 2269
2021
Q4
$2.7M Buy
+77,784
New +$2.47M 0.08% 260
2020
Q4
– Sell
-20,934
Closed -$309K – 925
2020
Q3
$309K Buy
+20,934
New +$378K 0.03% 503
2020
Q2
– Sell
-10,648
Closed -$151K – 605
2020
Q1
$151K Sell
10,648
-3,252
-23% -$49.3K 0.03% 503
2019
Q4
$226K Buy
+13,900
New +$329K 0.01% 1049
2019
Q3
– Sell
-4,790
Closed -$270K – 1866
2019
Q2
$270K Buy
+4,790
New +$345K 0.03% 787

Other funds holding ANAB

Walleye Capital's ANAB Position: Q3 2026 in Review

Walleye Capital opened a new position in AnaptysBio (ANAB) in Q3 2026: 8,695 shares worth $437K. The stake represents ﹤0.01% of the portfolio and ranks #4204 among its holdings. This is a return to the name: Walleye Capital previously reported a position in ANAB as recently as Q1 2026.

Walleye Capital first reported a position in ANAB in Q2 2019 and has held it in 12 quarters since. The position peaked at $5.49M in Q3 2024. 229 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Walleye Capital held 8,695 shares of AnaptysBio worth $437K as of Q3 2026.
  • AnaptysBio was a new Walleye Capital position in Q3 2026.
  • AnaptysBio made up ﹤0.01% of Walleye Capital's portfolio in Q3 2026, its #4204 holding.
  • Walleye Capital first reported a position in AnaptysBio in Q2 2019 and has held it in 12 quarters since.
  • Walleye Capital's AnaptysBio position peaked at $5.49M in Q3 2024.
  • 229 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.